Thinking of joining a study?

Register your interest

NCT02755974 | RECRUITING | Pulmonary Disease, Chronic Obstructive


The London COPD Exacerbation Cohort
Sponsor:

Imperial College London

Brief Summary:

The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.

Condition or disease

Pulmonary Disease, Chronic Obstructive

Detailed Description:

Our intentions are to phenotype Chronic Obstructive Pulmonary Disease (COPD) patients on the basis of factors that a related to (a) exacerbation frequency which will include (b) lung function to assess disease severity, (c) baseline therapy, (d) airway and systemic inflammatory markers, (e) health status, (f) gene expression, (g) airway bacterial and viral load and (h) co-morbidity including cardiovascular disease, diabetes and psychological disease, (i) psychological factors,(j) mortality, (k) nasal susceptibility to rhinovirus infection, (l) heart rate variability (m) exhaled hydrogen sulphide.

Study Type : OBSERVATIONAL
Estimated Enrollment : 300 participants
Official Title : Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
Actual Study Start Date : 2009-01
Estimated Primary Completion Date : 2026-12-31
Estimated Study Completion Date : 2026-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 40 Years to 100 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of \<0.70
  • * Able and willing to give informed and written consent
Exclusion Criteria
  • * Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.
  • * Patients on Immunosuppressive medications or with active cancer
  • * Long term steroid therapy
  • * Age \<40 years at recruitment

The London COPD Exacerbation Cohort

Location Details

NCT02755974


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United Kingdom,

National Heart and Lung Institute, Imperial College

London, United Kingdom, SW3 6LR

Loading...